In all of these models it is difficult to separate the relative contribution of intrinsic defects in cardiomyocyte insulin signaling from the conditions generated by the altered systemic metabolism, such as hyperglycaemia and hyperlipidaemia. The gene discussed is INS; the disease is Hyperglycemia.